Concurrent Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.71M Sell
66,494
-18,433
-22% -$1.49M 0.06% 363
2026
Q1
$7.36M Sell
84,927
-18,189
-18% -$1.74M 0.08% 271
2025
Q4
$9.91M Buy
103,116
+49,894
+94% +$4.85M 0.11% 186
2025
Q3
$5.07M Buy
53,222
+274
+0.5% +$25.2K 0.09% 238
2025
Q2
$4.62M Buy
52,948
+5,408
+11% +$459K 0.09% 238
2025
Q1
$4.27M Sell
47,540
-18,323
-28% -$1.64M 0.1% 216
2024
Q4
$5.26M Sell
65,863
-173
-0.3% -$15K 0.14% 151
2024
Q3
$5.95M Buy
66,036
+4,868
+8% +$410K 0.18% 124
2024
Q2
$4.81M Buy
61,168
+21,678
+55% +$1.78M 0.16% 142
2024
Q1
$3.44M Buy
39,490
+12,345
+45% +$1.05M 0.14% 161
2023
Q4
$2.24M Buy
+27,145
New +$2.07M 0.11% 207

Other funds holding MDT

Concurrent Investment Advisors's MDT Position: Q2 2026 in Review

Concurrent Investment Advisors reduced its Medtronic (MDT) stake by 22% in Q2 2026, selling an estimated $1.49M and leaving 66,494 shares worth $6.71M. The position accounts for 0.06% of the portfolio, ranked #363.

Concurrent Investment Advisors first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.91M in Q4 2025. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Concurrent Investment Advisors held 66,494 shares of Medtronic worth $6.71M as of Q2 2026.
  • Concurrent Investment Advisors sold 18,433 Medtronic shares in Q2 2026, an estimated $1.49M.
  • Medtronic made up 0.06% of Concurrent Investment Advisors's portfolio in Q2 2026, its #363 holding.
  • Concurrent Investment Advisors first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Concurrent Investment Advisors's Medtronic position peaked at $9.91M in Q4 2025.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.